NCAPD2 is a novel marker for the poor prognosis of lung adenocarcinoma and is associated with immune infiltration and tumor mutational burden

por Li, Zihao, Zheng, Yuxuan, Wu, Zuotao, Zhuo, Ting, Zhu, Yongjie, Dai, Lei, Wang, Yongyong, Chen, Mingwu
Publicado 2023

High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformat...

por Wu, Zuotao, Zhuo, Ting, Li, Zihao, Zhu, Yongjie, Wu, Jiejing, Liang, Guanbiao, Dai, Lei, Wang, Yongyong, Tan, Xiang, Chen, Mingwu
Publicado 2023